AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇨🇮
DACLATASVIR in Côte d'Ivoire
4 products registered with AIRP — 0 active, 4 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DACLAR 60MG COMPRIME BOITE DE 28 | E-2018-0437 | LABORATOIRE PHARMACEUTIQUE GALENICA | expired | 24 Jan 2023 |
| VIDAC 60MG COMPRIME PELLICULE BOITE DE 28 | E-2018-0375 | HETERO LABS LIMITED | expired | 23 Jan 2023 |
| VIDAC 30MG COMPRIME PELLICULE BOITE DE 28 | E-2018-0376 | HETERO LABS LIMITED | expired | 23 Jan 2023 |
| DAKTAVIRA 60MG COMPRIME BOITE DE 30 | E-2015-1317 | LABORATOIRE EUROPEAN EGYPTIAN PHARMACEUT | expired | 13 Jan 2021 |
DACLATASVIR — AIRP Registration Details
AIRP (Côte d'Ivoire) has 4 registered products containing DACLATASVIR, of which 0 are currently active. Data is sourced directly from the official AIRP drug register and refreshed daily.
Track DACLATASVIR registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.